Article

Understanding the Pharma Manufacturer's Dilemma

November 18, 2021
Understanding the Pharma Manufacturer's Dilemma Teaser

In this article, "Understanding the Pharma Manufacturer's Dilemma" Ravi Samavedam, Chief Innovation Officer (CINO), explains how Azzur Group's hybrid model and additional services help clients get their innovations to market within several months versus the typical multi-year effort.

Read the full article featured in Contract Pharma to find out answers regarding how laboratory innovations are solving the "build versus buy" dilemma. 


CLICK HERE TO READ MORE